|
|
|
Volumn 129, Issue 9, 2013, Pages 923-930
|
|
[Novel drugs provide better therapy for prostate cancer].;Uusilla lääkkeillä parempaa hoitoa eturauhassyöpään.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE;
ACETYL 2 NAPHTHYLALANYL 3 CHLOROPHENYLALANYL 1 OXOHEXADECYL SERYL 4 AMINOPHENYLALANYL(HYDROOROTYL) 4 AMINOPHENYLALANYL(CARBAMOYL) LEUCYL ILYS PROLYL ALANINAMIDE;
ACETYL-2-NAPHTHYLALANYL-3-CHLOROPHENYLALANYL-1-OXOHEXADECYL-SERYL-4-AMINOPHENYLALANYL(HYDROOROTYL)-4-AMINOPHENYLALANYL(CARBAMOYL)-LEUCYL-ILYS-PROLYL-ALANINAMIDE;
ANDROSTANE DERIVATIVE;
ANTINEOPLASTIC AGENT;
CABAZITAXEL;
DENOSUMAB;
DRUG DERIVATIVE;
ENZALUTAMIDE;
GONADORELIN;
MONOCLONAL ANTIBODY;
OLIGOPEPTIDE;
PHENYLTHIOHYDANTOIN;
RADIOISOTOPE;
RADIUM;
RADIUM CHLORIDE RA 223;
TAXOID;
DRUG ANTAGONISM;
HUMAN;
MALE;
PROSTATE TUMOR;
REVIEW;
ANDROSTENOLS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
MALE;
OLIGOPEPTIDES;
PHENYLTHIOHYDANTOIN;
PROSTATIC NEOPLASMS;
RADIOISOTOPES;
RADIUM;
TAXOIDS;
|
|
EID: 84880070236
PISSN: 00127183
EISSN: None
Source Type: None
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
